Andersen-Tawil syndrome diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (23 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Andersen-Tawil syndrome}} | {{Andersen-Tawil syndrome}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{VKG}} | ||
== | ==Overview== | ||
The diagnosis of Andersen-Tawil syndrome (ATS) is suspected in individuals | The [[diagnosis]] of [[Andersen-Tawil syndrome]] ([[Andersen-Tawil syndrome|ATS]]) is suspected in individuals whose satisfies either '''criteria A''' and '''criteria''' B with [[Molecule|molecular]] [[Genetics|genetic]] [[testing]] to confirm. | ||
A. Two of the following three criteria: | |||
== Diagnostic Study of Choice == | |||
*[[Phenotype|Phenotypic]] and [[Genotyping|genotypic]] evaluation of the patient is the [[Gold standard (test)|gold standard]] test for the [[diagnosis]] of [[Andersen-Tawil syndrome]] ([[Andersen-Tawil syndrome|ATS]]) which include A and B. | |||
* | |||
'''A Criteria''' | |||
* Two features has to to positive out of the following three criteria for [[Andersen-Tawil syndrome]] ([[Andersen-Tawil syndrome|ATS]]) :<ref name="pmid29125635">{{cite journal| author=Statland JM, Fontaine B, Hanna MG, Johnson NE, Kissel JT, Sansone VA | display-authors=etal| title=Review of the Diagnosis and Treatment of Periodic Paralysis. | journal=Muscle Nerve | year= 2018 | volume= 57 | issue= 4 | pages= 522-530 | pmid=29125635 | doi=10.1002/mus.26009 | pmc=5867231 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29125635 }}</ref><ref name="pmid11371347">{{cite journal| author=Plaster NM, Tawil R, Tristani-Firouzi M, Canún S, Bendahhou S, Tsunoda A | display-authors=etal| title=Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. | journal=Cell | year= 2001 | volume= 105 | issue= 4 | pages= 511-9 | pmid=11371347 | doi=10.1016/s0092-8674(01)00342-7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11371347 }}</ref><ref name="pmid15534250">{{cite journal| author=Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R | display-authors=etal| title=Correlating phenotype and genotype in the periodic paralyses. | journal=Neurology | year= 2004 | volume= 63 | issue= 9 | pages= 1647-55 | pmid=15534250 | doi=10.1212/01.wnl.0000143383.91137.00 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15534250 }}</ref><ref name="pmid24305449">{{cite journal| author=Statland JM, Barohn RJ| title=Muscle channelopathies: the nondystrophic myotonias and periodic paralyses. | journal=Continuum (Minneap Minn) | year= 2013 | volume= 19 | issue= 6 Muscle Disease | pages= 1598-614 | pmid=24305449 | doi=10.1212/01.CON.0000440661.49298.c8 | pmc=4234136 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24305449 }}</ref> | |||
* | |||
B | #[[Periodic paralysis]] | ||
#[[Cardiac arrhythmia|Cardiac arrhythmias]] which are supposed to be symptomatic or positive [[U waves|U-waves]] or a prolonged [[QT interval|QTc]] or QUc interval on [[The electrocardiogram|ECG]]. | |||
#Unique [[facial]] characteristics, [[dental]] problems and distinctive [[skeletal]] features, with 2 of the following which include: | |||
#*[[Low-set ears]] | |||
#* Widely spaced eyes | |||
#* Small [[mandible]] | |||
#* Fifth-digit [[clinodactyly]] | |||
#*[[Syndactyly]] of toes 2 and 3 | |||
'''B Criteria''' | |||
* Along with one of the above three criteria AND at least one of the other family member who meets two of the three criteria should be considered for further [[Gene|gene testing]] in patients with [[Andersen-Tawil syndrome]] ([[Andersen-Tawil syndrome|ATS]]). | |||
=== Molecular genetic testing === | |||
* Once the [[Phenotypically|phenotypic]] diagnosis is established and comprehensive [[genetic testing]] should be the next step in the [[diagnosis]] of [[Andersen-Tawil syndrome]] ([[Andersen-Tawil syndrome|ATS]]) patients to detect ''[[KCNJ2]]'', ''[[KCNJ5]]'' [[gene]] mutations which can be achieved by the following:<ref name="pmid12045162">{{cite journal| author=Ai T, Fujiwara Y, Tsuji K, Otani H, Nakano S, Kubo Y | display-authors=etal| title=Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia. | journal=Circulation | year= 2002 | volume= 105 | issue= 22 | pages= 2592-4 | pmid=12045162 | doi=10.1161/01.cir.0000019906.35135.a3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12045162 }}</ref><ref name="pmid12032359">{{cite journal| author=Preisig-Müller R, Schlichthörl G, Goerge T, Heinen S, Brüggemann A, Rajan S | display-authors=etal| title=Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. | journal=Proc Natl Acad Sci U S A | year= 2002 | volume= 99 | issue= 11 | pages= 7774-9 | pmid=12032359 | doi=10.1073/pnas.102609499 | pmc=124349 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12032359 }}</ref> | |||
**'''Gene-targeted testing''' | |||
***Gene-targeted testing which includes single-gene testing and multigene panel | |||
**'''Comprehensive''' '''genomic testing''' | |||
***Comprehensive [[genomic]] testing which includes [[exon]] sequencing and [[genome]] [[sequencing]]. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
[[Category:Disease]] | [[Category:Rare Disease]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Latest revision as of 15:02, 17 February 2020
|
Andersen-Tawil syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Andersen-Tawil syndrome diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Andersen-Tawil syndrome diagnostic criteria |
|
Risk calculators and risk factors for Andersen-Tawil syndrome diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
The diagnosis of Andersen-Tawil syndrome (ATS) is suspected in individuals whose satisfies either criteria A and criteria B with molecular genetic testing to confirm.
Diagnostic Study of Choice
- Phenotypic and genotypic evaluation of the patient is the gold standard test for the diagnosis of Andersen-Tawil syndrome (ATS) which include A and B.
A Criteria
- Two features has to to positive out of the following three criteria for Andersen-Tawil syndrome (ATS) :[1][2][3][4]
- Periodic paralysis
- Cardiac arrhythmias which are supposed to be symptomatic or positive U-waves or a prolonged QTc or QUc interval on ECG.
- Unique facial characteristics, dental problems and distinctive skeletal features, with 2 of the following which include:
- Low-set ears
- Widely spaced eyes
- Small mandible
- Fifth-digit clinodactyly
- Syndactyly of toes 2 and 3
B Criteria
- Along with one of the above three criteria AND at least one of the other family member who meets two of the three criteria should be considered for further gene testing in patients with Andersen-Tawil syndrome (ATS).
Molecular genetic testing
- Once the phenotypic diagnosis is established and comprehensive genetic testing should be the next step in the diagnosis of Andersen-Tawil syndrome (ATS) patients to detect KCNJ2, KCNJ5 gene mutations which can be achieved by the following:[5][6]
- Gene-targeted testing
- Gene-targeted testing which includes single-gene testing and multigene panel
- Comprehensive genomic testing
- Comprehensive genomic testing which includes exon sequencing and genome sequencing.
- Gene-targeted testing
References
- ↑ Statland JM, Fontaine B, Hanna MG, Johnson NE, Kissel JT, Sansone VA; et al. (2018). "Review of the Diagnosis and Treatment of Periodic Paralysis". Muscle Nerve. 57 (4): 522–530. doi:10.1002/mus.26009. PMC 5867231. PMID 29125635.
- ↑ Plaster NM, Tawil R, Tristani-Firouzi M, Canún S, Bendahhou S, Tsunoda A; et al. (2001). "Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome". Cell. 105 (4): 511–9. doi:10.1016/s0092-8674(01)00342-7. PMID 11371347.
- ↑ Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R; et al. (2004). "Correlating phenotype and genotype in the periodic paralyses". Neurology. 63 (9): 1647–55. doi:10.1212/01.wnl.0000143383.91137.00. PMID 15534250.
- ↑ Statland JM, Barohn RJ (2013). "Muscle channelopathies: the nondystrophic myotonias and periodic paralyses". Continuum (Minneap Minn). 19 (6 Muscle Disease): 1598–614. doi:10.1212/01.CON.0000440661.49298.c8. PMC 4234136. PMID 24305449.
- ↑ Ai T, Fujiwara Y, Tsuji K, Otani H, Nakano S, Kubo Y; et al. (2002). "Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia". Circulation. 105 (22): 2592–4. doi:10.1161/01.cir.0000019906.35135.a3. PMID 12045162.
- ↑ Preisig-Müller R, Schlichthörl G, Goerge T, Heinen S, Brüggemann A, Rajan S; et al. (2002). "Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome". Proc Natl Acad Sci U S A. 99 (11): 7774–9. doi:10.1073/pnas.102609499. PMC 124349. PMID 12032359.